BioCentury
ARTICLE | Company News

Medigene, Sinphar Pharmaceutical deal

June 10, 2013 7:00 AM UTC

Medigene and Sinphar's SynCore Biotechnology Co. Ltd. subsidiary amended a 2012 deal to give SynCore worldwide commercialization rights to EndoTAG-1. SynCore previously had rights to EndoTAG-1 in Asi...